Abstract
Abstract
The chemical composition of a “heparin analog” (A73025) was studied and its biologic properties were compared with those of a heparin preparation from intestinal mucosa. A73025 was characterized as a polysulfated chondroitin with a molecular weight of about 10,000 M r. Unlike heparin, A73025 showed poor anticoagulant activity in vitro by Stypven clotting time, partial thromboplastin time, and thrombin time assays. A73025, like heparin, although to a lesser extent, inhibited thrombin induced platelet aggregation, released lipoprotein lipase when injected into rabbits, and complexed with serum low and very low density lipoproteins.
Get full access to this article
View all access options for this article.
